News
COVID-19 vaccine supply will be limited at first, ACIP says
August 27, 2020
The working group expects that from 15 to 45 million doses of vaccine will be available by the end of December, depending on which vaccine is approved by then or whether both are approved.
![1]()
News
Asymptomatic SARS-CoV-2 infections in kids tied to local rates
August 27, 2020
It is unclear how many children remain asymptomatic in comparison with those who were in a presymptomatic phase at the time of testing.
News
Convalescent plasma actions spark trial recruitment concerns
August 26, 2020
“It’s not clear that people with COVID-19, especially those who are severely ill and hospitalized, will choose to enlist in a clinical trial – where they could receive a placebo – when they instead could get plasma.”
![1]()
News
Prognosis for rural hospitals worsens with pandemic
August 26, 2020
It’s a dangerous scenario. “We know that a closure leads to higher mortality pretty quickly” among the populations served.
![1]()
Opinion
Being a pediatric hospitalist during the COVID-19 pandemic
August 26, 2020
These times are unsettling for the pediatric hospitalist community.
![1]()
News
When viruses collide: Flu season during pandemic
August 26, 2020
Seasonal flu in the midst of the COVID-19 pandemic threatens to overwhelm practitioners, hospitals and the health care system.
![1]()
News
As COVID-19 cases increase in children, deaths remain low
August 25, 2020
Tennessee passed Arizona this week and now has the highest rate of cumulative cases.
News
First evidence of SARS-CoV-2 in heart cells
August 25, 2020
SARS-CoV-2 has been found in cardiac tissue of a child with multisystem inflammatory syndrome related to COVID-19, believed to be first evidence of direct infection of heart muscle cells by the virus.
![1]()
News
Famotidine associated with benefits in hospitalized COVID patients in another trial
August 25, 2020
“The mechanism of exactly how famotidine works has yet to be proven,” lead study author Jeffrey F. Mather said.
News
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
August 25, 2020
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.
